Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
University of Chicago
University of Chicago
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Celgene
Children's Oncology Group
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Children's Oncology Group
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
M.D. Anderson Cancer Center